S1 Biopharma, Inc.   Report issue

For profit Phase 2
Founded: New York NY United States (2010)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2013
NCT01857596
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Chief Medical Officer, S1 Biopharma, Inc.